stanozolol has been researched along with Familial Precocious Puberty in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hu, Y; Li, Y; Long, L; Tuo, Y; Yu, Z; Zhu, S | 1 |
Chen, HS; Chen, QL; Du, ML; Gu, YF; Li, YH; Ma, HM; Su, Z; Zhu, SY | 1 |
Dou, J; Du, ML; Huang, TT; Li, YH; Luo, HB; Ma, HM; Zhu, SY | 1 |
1 trial(s) available for stanozolol and Familial Precocious Puberty
Article | Year |
---|---|
[Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
Topics: Body Height; Bone Development; Child; Child Development; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Growth Disorders; Human Growth Hormone; Humans; Puberty, Precocious; Stanozolol; Treatment Outcome | 2013 |
2 other study(ies) available for stanozolol and Familial Precocious Puberty
Article | Year |
---|---|
GnRHa/Stanozolol Combined Therapy Maintains Normal Bone Growth in Central Precocious Puberty.
Topics: Anabolic Agents; Animals; Bone Development; Cell Line; Chondrocytes; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Growth Plate; Humans; Mesenchymal Stem Cells; Puberty, Precocious; Rats; Rats, Sprague-Dawley; Stanozolol | 2021 |
Stanozolol regulates proliferation of growth plate chondrocytes via activation of ERalpha in GnRHa-treated adolescent rats.
Topics: Animals; Binding Sites; Body Height; Cell Proliferation; Child; Chondrocytes; Disease Models, Animal; Estrogen Receptor alpha; Female; Gonadotropin-Releasing Hormone; Growth Plate; Humans; Male; MAP Kinase Signaling System; Molecular Dynamics Simulation; Phosphorylation; Puberty, Precocious; Rats; Receptors, Androgen; Stanozolol | 2011 |